Related Experiment Videos
[Prognostic factors in patients with differentiated thyroid carcinoma]
Jacek Makarewicz1, Andrzej Lewiński
1Klinika Endokrynologii i Terapii Izotopowej, Uniwersytet Medyczny, Łódź
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|March 15, 2005
Summary
Differentiated thyroid carcinoma usually has a good prognosis, but some patients face an unfavorable course. Identifying prognostic factors early aids in timely, appropriate treatment for these individuals.
Area of Science:
- Oncology
- Endocrinology
- Pathology
Context:
- Differentiated thyroid carcinoma (DTC) is a common endocrine malignancy.
- While generally curable, a subset of DTC patients exhibits aggressive disease progression.
- Early identification of high-risk DTC patients is crucial for optimizing treatment strategies.
Purpose:
- To identify and present the primary prognostic factors influencing the clinical course of differentiated thyroid carcinoma.
- To aid clinicians in stratifying DTC patients based on predicted outcomes.
- To facilitate the timely implementation of tailored therapeutic interventions for patients with unfavorable prognoses.
Summary:
- Differentiated thyroid carcinoma (DTC) is a thyroid gland neoplasm.
- Prognostic factors are presented for DTC patients.
- Early identification of patients with unfavorable DTC courses is emphasized.
Impact:
- Improved patient stratification for differentiated thyroid carcinoma.
- Enhanced clinical decision-making in DTC management.
- Potential for improved therapeutic outcomes in high-risk DTC populations.